#primary_sclerosing_cholangitis
doi.org/10.1042/BCJ2...: When a drug is effective, but has a narrow therapeutic window. Either throw it out, or try to improve it. Ariane and Audrey-Anne have explored this second option for Ocaliva.
#primary_biliary_cholangitis
#primary_sclerosing_cholangitis
#Ocaliva
#Pharmaco-nutraceutics
July 26, 2025 at 1:55 PM